2-Amino Thiazole Derivatives as Prospective Aurora Kinase Inhibitors against Breast Cancer: QSAR, ADMET Prediction, Molecular Docking, and Molecular Dynamic Simulation Studies.


Journal

ACS omega
ISSN: 2470-1343
Titre abrégé: ACS Omega
Pays: United States
ID NLM: 101691658

Informations de publication

Date de publication:
21 Nov 2023
Historique:
received: 13 09 2023
revised: 05 10 2023
accepted: 23 10 2023
medline: 29 11 2023
pubmed: 29 11 2023
entrez: 29 11 2023
Statut: epublish

Résumé

The aurora kinase is a key enzyme that is implicated in tumor growth. Research revealed that small molecules that target aurora kinase have beneficial effects as anticancer agents. In the present study, in order to identify potential antibreast cancer agents with aurora kinase inhibitory activity, we employed QSARINS software to perform the quantitative structure-activity relationship (QSAR). The statistical values resulted from the study include

Identifiants

pubmed: 38027360
doi: 10.1021/acsomega.3c07003
pmc: PMC10666282
doi:

Types de publication

Journal Article

Langues

eng

Pagination

44287-44311

Informations de copyright

© 2023 The Authors. Published by American Chemical Society.

Déclaration de conflit d'intérêts

The authors declare no competing financial interest.

Références

Anticancer Agents Med Chem. 2020;20(9):1115-1128
pubmed: 32000647
Mini Rev Med Chem. 2018;18(8):640-655
pubmed: 29173166
Front Chem. 2021 Oct 25;9:757584
pubmed: 34765587
Bioorg Med Chem Lett. 2015 May 1;25(9):1856-63
pubmed: 25845281
Struct Chem. 2022;33(4):1063-1084
pubmed: 35345415
Eur J Med Chem. 2016 Aug 25;119:70-82
pubmed: 27155464
Eur J Med Chem. 2020 Feb 15;188:112016
pubmed: 31926469
J Mol Graph Model. 2020 Dec;101:107751
pubmed: 32961479
SAR QSAR Environ Res. 2023 Feb;34(2):91-116
pubmed: 36744430
J Med Chem. 2010 Jun 10;53(11):4367-78
pubmed: 20462263
J Mol Struct. 2022 Jun 15;1258:132652
pubmed: 35194243
Eur J Med Chem. 2015 Jun 5;97:699-718
pubmed: 25934508
J Mol Graph Model. 1999 Feb;17(1):57-61
pubmed: 10660911
ACS Chem Biol. 2008 Mar 20;3(3):180-92
pubmed: 18307303
Molecules. 2021 May 11;26(10):
pubmed: 34064806
RSC Med Chem. 2022 Jan 3;13(3):327-342
pubmed: 35434623
Molecules. 2022 Jan 19;27(3):
pubmed: 35163913
Future Med Chem. 2019 Aug;11(15):1929-1952
pubmed: 31313595
Molecules. 2022 Mar 11;27(6):
pubmed: 35335208
Exp Mol Med. 2021 May;53(5):835-847
pubmed: 34050264
SAR QSAR Environ Res. 2023 Feb;34(2):117-146
pubmed: 36744427
J Cheminform. 2015 Dec 09;7:60
pubmed: 26664458
J Mol Model. 2022 Mar 29;28(4):106
pubmed: 35352175
J Comput Aided Mol Des. 2019 Sep;33(9):831-844
pubmed: 31628660
Curr Comput Aided Drug Des. 2016;12(3):229-240
pubmed: 27264509
Sci Rep. 2017 Mar 03;7:42717
pubmed: 28256516
Heliyon. 2020 Apr 14;6(4):e03724
pubmed: 32322718
J Enzyme Inhib Med Chem. 2022 Dec;37(1):701-717
pubmed: 35168458
Sci Rep. 2022 Sep 30;12(1):16368
pubmed: 36180452
Mutat Res. 2020 May - Dec;821:111716
pubmed: 32738522
Pharmacol Ther. 2013 May;138(2):255-71
pubmed: 23356980
J King Saud Univ Sci. 2021 Mar;33(2):101352
pubmed: 33558797
Chem Biol Drug Des. 2010 Dec;76(6):527-37
pubmed: 21040493
Eur J Pharm Sci. 2019 Jun 15;134:20-30
pubmed: 30965082
ACS Omega. 2023 Jan 19;8(4):4294-4319
pubmed: 36743017
J Cheminform. 2011 Oct 07;3:33
pubmed: 21982300
J Med Chem. 2021 Oct 14;64(19):14046-14128
pubmed: 34591488
Pharmaceutics. 2022 Jan 19;14(2):
pubmed: 35213965
J Cheminform. 2012 Aug 13;4(1):17
pubmed: 22889332
Eur J Med Chem. 2021 Oct 5;221:113495
pubmed: 34020340
CA Cancer J Clin. 2023 Jan;73(1):17-48
pubmed: 36633525
Res Pharm Sci. 2021 Aug 19;16(5):528-546
pubmed: 34522200
J Comput Chem. 2014 May 15;35(13):1036-44
pubmed: 24599647
Curr Org Synth. 2022 Aug 6;19(6):702-730
pubmed: 35170413
Heliyon. 2019 Mar 07;5(3):e01304
pubmed: 30899832
Life (Basel). 2022 Feb 20;12(2):
pubmed: 35207602
Curr Top Med Chem. 2016;16(26):2841-2862
pubmed: 27150376
J Chem Inf Model. 2011 Oct 24;51(10):2778-86
pubmed: 21919503
Mol Inform. 2012 Jul;31(6-7):453-8
pubmed: 27477464
Biochim Biophys Acta. 2008 Sep;1786(1):60-72
pubmed: 18662747
Molecules. 2021 May 25;26(11):
pubmed: 34070661
Molecules. 2021 Apr 01;26(7):
pubmed: 33915740
Nat Rev Mol Cell Biol. 2001 Jan;2(1):21-32
pubmed: 11413462
Front Pharmacol. 2021 Nov 25;12:764351
pubmed: 34899321
ACS Omega. 2021 Dec 22;7(1):875-899
pubmed: 35036753

Auteurs

Sivakumar Bathula (S)

Department of Pharmaceutical Chemistry, SRM College of Pharmacy, SRM Institute of Science and Technology, Kattankulathur 603203, Chengalpattu District, Tamil Nadu, India.

Murugesan Sankaranarayanan (M)

Medicinal Chemistry Research Laboratory, Department of Pharmacy, Birla Institute of Technology & Science (BITS) Pilani, Pilani Campus, Pilani 333031, Rajasthan, India.

Beutline Malgija (B)

MCC-MRF Innovation Park, Madras Christian College, Chennai 600059, Tamil Nadu, India.

Ilango Kaliappan (I)

Department of Pharmaceutical Chemistry, SRM College of Pharmacy, SRM Institute of Science and Technology, Kattankulathur 603203, Chengalpattu District, Tamil Nadu, India.

Richie R Bhandare (RR)

Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, Ajman University, P.O. Box 346, Ajman 61001, United Arab Emirates.
Centre of Medical and Bio-allied Health Sciences Research, Ajman University, P.O. Box 346, Ajman 61001, United Arab Emirates.

Afzal B Shaik (AB)

St. Mary's College of Pharmacy, St. Mary's Group of Institutions Guntur, Affiliated to Jawaharlal Nehru Technological University Kakinada, Chebrolu, Guntur 522212, Andhra Pradesh, India.
Center for Global Health Research, Saveetha Medical College, Saveetha Institute of Medical and Technical Sciences, Chennai 602105, Tamil Nadu, India.

Classifications MeSH